These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10678787)

  • 1. New advances in the use of antimicrobial agents in surgery: intra-abdominal infections.
    Cinat ME; Wilson SE
    J Chemother; 1999 Dec; 11(6):453-63. PubMed ID: 10678787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of beta-lactam antimicrobials as single agents in treatment of intra-abdominal infection.
    Powell LL; Wilson SE
    Surg Infect (Larchmt); 2000; 1(1):57-63. PubMed ID: 12594910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
    Goldstein EJ; Snydman DR
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii29-36. PubMed ID: 15150181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated pharmacokinetic-pharmacodynamic modelling to evaluate antimicrobial prophylaxis in abdominal surgery.
    Zelenitsky SA; Lawson C; Calic D; Ariano RE; Roberts JA; Lipman J; Zhanel GG
    J Antimicrob Chemother; 2016 Oct; 71(10):2902-8. PubMed ID: 27402005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric treatment of nosocomial intra-abdominal infections: a focus on the carbapenems.
    Tellado JM; Wilson SE
    Surg Infect (Larchmt); 2005; 6(3):329-43. PubMed ID: 16201943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial chemotherapy in the control of surgical infectious complications.
    de Lalla F
    J Chemother; 1999 Dec; 11(6):440-5. PubMed ID: 10678785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae.
    Appelbaum PC
    Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected overview of nongynecologic surgical intra-abdominal infections. Prophylaxis and therapy.
    Levin S; Goodman LJ
    Am J Med; 1985 Nov; 79(5B):146-56. PubMed ID: 3934966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of moxifloxacin for the treatment of community-acquired [corrected] complicated intra-abdominal infections in Taiwan.
    Lau YJ; Chen YH; Huang CT; Lee WS; Liu CY; Liu JW; Liu HD; Lee YJ; Chen CW; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2012 Feb; 45(1):1-6. PubMed ID: 22244019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of clinical trials of antimicrobial agents in surgery.
    Dellinger EP
    Surg Gynecol Obstet; 1991; 172 Suppl():65-72. PubMed ID: 2024229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
    Giamarellou H
    J Chemother; 1999 Dec; 11(6):486-93. PubMed ID: 10678790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
    Calbo E; Garau J
    Respiration; 2005; 72(6):561-71. PubMed ID: 16354997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial treatment for intra-abdominal infections.
    Mazuski JE
    Expert Opin Pharmacother; 2007 Dec; 8(17):2933-45. PubMed ID: 18001254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial agents for the prevention and treatment of abdominal infections: a new generation?
    Rotstein OD
    Am J Surg; 1998 Dec; 176(6A Suppl):80S-83S. PubMed ID: 9935262
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH; Jones RN; Malledant J; Privitera G
    J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N; Nendaz M
    Rev Med Suisse; 2006 Jan; 2(50):289-90, 292-4. PubMed ID: 16503046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.